https://investors.modernatx.com/news-releases/news-release-d...
https://investors.modernatx.com/news-releases/news-release-d...
This is called "biobucks" in the industry. There's an incentive to close big deals for management and business types in biotech, so they love to craft these large headlines to drop it on their resume and grift at another big pharma.
I'd be surprised if they ever received the $180MM, although $240MM upfront is really impressive.
The larger point is that Moderna was flush with cash for years before COVID, and the DARPA money wasn't that 'crazy' of an investment, or essential to Moderna's progress.
This is a good outcome, the money wasn't 'wasted' since it spurred development in a particular area of interest to DARPA - advanced robotics.